> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Anne’s Daye Pulls CBD Tampons in U.S.
- URL: https://www.fdaweb.com/annes-daye-pulls-cbd-tampons-in-u-s/
- Published: 2025-01-08T12:00:00.000Z
- Updated: 2026-09-14T14:50:22.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5158454

The UK-based maker of Anne’s Daye Tampons says it is pulling its CBD-coated tampons intended to relieve menstrual pain from the U.S. market following receipt of an FDA [Warning Letter](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/annes-daye-ltd-dba-tampon-innovations-696362-12172024?ref=fdaweb.com). The letter said the adulterated products were not approved for sale in the U.S. and were misbranded due to the addition of cannabinoids.

An online *Marijuana Moment* [post](https://www.marijuanamoment.net/cbd-tampon-maker-pulls-products-off-u-s-market-following-fda-warning-letter/?ref=fdaweb.com) says FDA indicated the company had not notified the agency of changes and modifications to the tampons that could significantly affect their safety or efficacy.

“In light of this feedback and given the sensitive regulatory landscape surrounding cannabinoids in medical devices within the U.S.,” the company told the newsletter, “we have made the decision to voluntarily remove the CBD Daye Tampons from the U.S. market while we evaluate alternative pathways to regulatory compliance. We are actively working with FDA to address their concerns and clarify any misunderstandings about our products’ regulatory status.” FDA declined to comment on an open compliance matter to *Marijuana Moment*.